Skip to content

A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)

A Consumer Use Study of OTC Lovastatin (CUSTOM): A 6-Month Consumer Behavior Study of the Lovastatin OTC Self-Management System

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00092846
Enrollment
1000
Registered
2004-09-28
Start date
2002-12-04
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia

Keywords

High Blood Cholesterol Levels

Brief summary

The purpose of this study is to evaluate the ability of patients with intermediate risk of heart disease to appropriately use a Self-Management System.

Detailed description

The duration of treatment is 6 months.

Interventions

DRUGMK0803, lovastatin
BEHAVIORALSelf-Management System

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Must be able to read and understand English without assistance. * For Males: Minimum age 45 years and Maximum age N/A (No limit). * For Females: Minimum age 55 years and Maximum age N/A (No limit).

Exclusion criteria

* Pregnant or nursing * Drug allergy

Design outcomes

Primary

MeasureTime frame
Percentage of patients who make appropriate decision for self-management.

Secondary

MeasureTime frame
Percentage of patients who make appropriate decision to discontinue therapy or consult with a physician; the incidence of adverse experiences.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026